Nuwellis, Inc. Form 8-K Summary
Business Context and Reporting Period
Nuwellis, Inc. (Nuwellis) filed this Current Report on Form 8-K on July 24, 2024, to disclose the entry into material definitive agreements regarding a capital raise. The company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol "NUWE".
Key Financial Metrics and Transaction Details
This filing details a registered direct offering and a concurrent private placement. The filing does not provide historical revenue, profit, cash flow, or margin data as it is a current report on a specific event rather than a periodic financial statement.
- Shares Sold: 469,340 shares of Common Stock.
- Offering Price: $4.24 per share.
- Warrants Issued: Warrants to purchase up to 938,680 shares of Common Stock.
- Warrant Terms: Exercise price of $3.99 per share; immediately exercisable; expire five years from issuance.
- Net Proceeds: Approximately $1.6 million (after deducting fees and expenses).
- Use of Proceeds: Working capital and general corporate purposes.
- Placement Fee: 7.0% of gross proceeds paid to Roth Capital Partners, LLC.
Material Changes and Agreements
The primary material change is the execution of a Placement Agency Agreement and a Securities Purchase Agreement. Key contractual terms include:
- Lock-Up Period: The Company agreed not to issue or announce the issuance of Common Stock or equivalents for 30 days post-closing.
- Variable Rate Transaction Restriction: The Company agreed not to effect any Variable Rate Transactions for 180 days post-closing.
- Right of Participation: Purchasers were granted a 12-month right to participate in up to 40% of any subsequent equity or debt financing on the same terms.
- Registration Obligation: The Company must file a registration statement for the Common Warrant Shares within 30 days of closing and have it declared effective within 60 days.
Outlook, Risks, and Management Commentary
Management intends to utilize the net proceeds for working capital and general corporate purposes. The offering is expected to close on or about July 25, 2024, subject to customary closing conditions. The filing notes that the description of agreements is qualified by reference to the full text of the exhibits. No specific forward-looking guidance regarding future revenue or earnings was provided in this document.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds received, as the filing states the close is expected "on or about" July 25, 2024.
- Review the full text of the Placement Agency Agreement (Exhibit 10.1) and Securities Purchase Agreement (Exhibit 10.2) for specific representations and warranties.
- Monitor the filing of the registration statement for the Common Warrant Shares, which is required within 30 days of closing.
- Assess the dilution impact of the 938,680 warrants issued, which are immediately exercisable at $3.99 per share.
- Check for any subsequent filings regarding the 30-day lock-up expiration or the 180-day variable rate transaction restriction.